ACTION POTENTIAL VENTURE CAPITAL

action-potential-venture-capital-logo

GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012... after a two-year effort to seek out and engage the most promising researchers in this emerging area of science. The name of the fund comes from electrical signals called action potentials that pass along the nerves in the body. Irregular or altered patterns of these impulses may occur in association with a broad range of diseases. GSK believes that miniaturised devices, or bioelectronic medicines, can be designed to read these patterns. The devices could be designed to interface between the peripheral nervous system and specific organs to read, change or generate electronic impulses that help treat disorders as diverse as inflammatory bowel disease or rheumatoid arthritis; respiratory diseases such as asthma and COPD and metabolic diseases including Type 2 diabetes. The field of bioelectronic medicines is in its very early stages. GSK’s ambition, through collaboration with scientists globally, is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.“We want to help create the medicines of the future and be the catalyst for this work,” said Moncef Slaoui, chairman of R&D and architect of GSK’s early stage investment strategy. “GSK can play the integrating role that is needed to drive this new type of medical treatment all the way from the bench to the patient and this fund is a key part of our efforts.” Action Potential Venture Capital intends to build a portfolio of five to seven companies over the next five years. The fund will focus investments in three areas: - New start-up companies that aim to pursue the vision of bioelectronic medicines - Existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses - Companies advancing technology platforms that will underpin these treatment modalities Action Potential Venture Capital will be based in Cambridge, Massachusetts and managed by a small, dedicated team. The fund has named Imran Eba as its first partner. Imran will move from GSK’s Worldwide Business Development organisation and work closely with the Bioelectronics R&D unit.

#SimilarOrganizations #People #Financial #More

ACTION POTENTIAL VENTURE CAPITAL

Social Links:

Industry:
Finance Venture Capital

Founded:
2013-01-01

Status:
Active

Contact:
(888) 825-5249

Technology used in webpage:
Google Google Cloud About Cookies


Similar Organizations

accomplice-logo

Accomplice

Accomplice is a seed-led venture capital firm that primarily invests in technology startup companies.

gp-healthcare-capital-logo

GP Healthcare Capital

GP Healthcare Capital is a venture capital that makes investments in companies based in the biotechnology industry.

redstar-ventures-logo

Redstar Ventures

Redstar Ventures is a Massachusetts-based micro venture capital that invests in startup and seed stage companies.

renovus-capital-partners-logo

Renovus Capital Partners

Renovus Capital Partners provides equity capital and strategic assistance to small and mid-sized education companies.

section-32-logo

Section 32

Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.

Current Employees Featured

juan-pablo-mas_image

Juan-Pablo Mas
Juan-Pablo Mas Partner @ Action Potential Venture Capital
Partner
2014-08-01

not_available_image

Imran Eba
Imran Eba Partner @ Action Potential Venture Capital
Partner
2013-08-01

isaac-b-stoner_image

Isaac B. Stoner
Isaac B. Stoner Summer Associate @ Action Potential Venture Capital
Summer Associate
2015-05-01

not_available_image

Ali Kight
Ali Kight Summer Associate @ Action Potential Venture Capital
Summer Associate
2023-06-01

jens-eckstein_image

Jens Eckstein
Jens Eckstein Director and Managing Partner @ Action Potential Venture Capital
Director and Managing Partner
2013-01-01

Investments List

Date Company Article Money raised
2024-07-15 NeuSpera Medical Action Potential Venture Capital investment in Series D - NeuSpera Medical 23 M USD
2023-06-26 Presidio Medical Action Potential Venture Capital investment in Series C - Presidio Medical 72 M USD
2023-04-13 Saluda Medical Action Potential Venture Capital investment in Venture Round - Saluda Medical 150 M USD
2023-01-19 SetPoint Medical Action Potential Venture Capital investment in Venture Round - SetPoint Medical 80 M USD
2023-01-05 Onc.AI Action Potential Venture Capital investment in Series A - Onc.AI 25 M USD
2022-11-10 Alpheus Medical Action Potential Venture Capital investment in Series A - Alpheus Medical 14 M USD
2022-06-20 MicroTransponder Action Potential Venture Capital investment in Series E - MicroTransponder 73 M USD
2021-11-17 Alpheus Medical Action Potential Venture Capital investment in Series A - Alpheus Medical 16 M USD
2021-07-20 NeuSpera Medical Action Potential Venture Capital investment in Series C - NeuSpera Medical 65 M USD
2021-01-27 SetPoint Medical Action Potential Venture Capital investment in Venture Round - SetPoint Medical 64 M USD

More informations about "Action Potential Venture Capital"

Team - APVC

Before joining Action Potential, Imran was in the Worldwide Business Development group of GSK working in a variety of business development and investing roles. ... was tasked with …See details»

Action Potential Venture Capital - Crunchbase

Action Potential Venture Capital will be based in Cambridge, Massachusetts and managed by a small, dedicated team. The fund has named Imran Eba as its first partner. Imran will move from GSK’s Worldwide Business Development …See details»

Action Potential Venture Capital - Investments, Portfolio

Action Potential Venture Capital has made 3 diversity investments. Their most recent diversity investment was on Dec 9, 2024 , when Cala Health raised obfuscatedSee details»

Action Potential Venture Capital investment portfolio - PitchBook

Jun 30, 2021 Action Potential Venture Capital's latest investment was on 10-Jan-2025 in Saluda Medical, a company within the Therapeutic Devices industry. Data Transparency. Meet our …See details»

Action Potential Venture Capital

Feb 10, 2025 Action Potential Venture Capital (APVC) is a leading medical Technology venture Capital firm founded by GSK in 2013. APVC invests globally and takes a handson role on the …See details»

ACTION POTENTIAL VENTURE CAPITAL LIMITED - Companies House

More for ACTION POTENTIAL VENTURE CAPITAL LIMITED (08603529) Registered office address Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, United Kingdom, …See details»

Action Potential Venture Capital - hub.waveup.com

Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GlaxoSmithKline (GSK) in 2013. The firm focuses on advancing bioelectronic …See details»

Action Potential Venture Capital - teaserclub.com

Action Potential Venture Capital is a strategic venture capital fund launched by GlaxoSmithKline, with a focus on investing in companies pioneering bioelectronic medicines and technologies. …See details»

Action Potential Venture Capital: Fund Performance - PitchBook

Action Potential Venture Capital is an early-stage venture capital fund managed by Action Potential Venture Capital. The fund is located in Cambridge, Massachusetts, and invests in the …See details»

Exo® | Investors | Exo

Action Potential Venture Capital (APVC) is an independent corporate venture arm of GlaxoSmithKline (GSK) that invests globally in companies developing bioelectronic medicines. This emerging field includes both non-invasive and …See details»

Action Potential Venture Capital - CB Insights

Jun 30, 2021 Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital. Jan 6, 2023. Venture Capital News | Private Equity News venture …See details»

An investor perspective on forming and funding your medical …

1 Action Potential Venture Capital, GlaxoSmithKline, Palo Alto, CA. Electronic address: juan-pablo.x.mas@actionpotentialvc.com. 2 Department of Bioengineering, Stanford University …See details»

Action Potential Venture Capital - Venture Capital Investor - Tracxn

Mar 17, 2025 Action Potential Venture Capital - Stage agnostic life sciences-focused VC firm investing primarily in the US. Portfolio of 12 companies. 29 investors have invested with Action …See details»

Action Potential Venture Capital - Portfolio, Partners, Reviews, News

Jun 17, 2023 Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices, …See details»

Action Potential Venture Capital - Crunchbase

Action Potential Venture Capital has 5 current employee profiles, including Partner Juan-Pablo Mas. Juan-Pablo Mas Partner. Imran Eba Partner. Isaac B. Stoner Summer Associate. Ali …See details»

Action Potential Venture Capital - ZoomInfo

Feb 10, 2023 Action Potential Venture Capital (APVC) is an independent corporate venture arm of GlaxoSmithKline (GSK). The firm invests globally in companies pu rsing the development of …See details»

Action Potential Venture Capital - Updates, News, Events, Signals ...

Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.See details»

Action Potential Venture Capital – Investors Database – Unicorn Nest

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Action Potential Venture Capital, startups are often financed by Morgenthaler Ventures, Boston …See details»

The Hottest Niches For Venture Capital In The Next Decade - Forbes

3 hours ago Total capital raised in the global venture capital market is projected to reach almost $286.3 billion in 2025. This signals even greater investment opportunities for venture capitalists.See details»

To Make Better Decisions, Think Like a Venture Capitalist

2 days ago April 02, 2025. Venture capital firms notoriously embrace risk and take big swings, hoping that one startup will become a monster hit that pays for many other failed investments.See details»

linkstock.net © 2022. All rights reserved